FR2665363B1 - Composition pharmaceutique comprenant une ou des bleomycines, et une ou des proteines inactivant les bleomycines. - Google Patents

Composition pharmaceutique comprenant une ou des bleomycines, et une ou des proteines inactivant les bleomycines.

Info

Publication number
FR2665363B1
FR2665363B1 FR9009753A FR9009753A FR2665363B1 FR 2665363 B1 FR2665363 B1 FR 2665363B1 FR 9009753 A FR9009753 A FR 9009753A FR 9009753 A FR9009753 A FR 9009753A FR 2665363 B1 FR2665363 B1 FR 2665363B1
Authority
FR
France
Prior art keywords
bleomycin
pharmaceutical composition
inactive protein
bleomycins
inactivating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9009753A
Other languages
English (en)
Other versions
FR2665363A1 (fr
Inventor
Durand Henri Paul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cayla
Original Assignee
Cayla
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cayla filed Critical Cayla
Priority to FR9009753A priority Critical patent/FR2665363B1/fr
Priority to PCT/FR1991/000623 priority patent/WO1992002230A1/fr
Publication of FR2665363A1 publication Critical patent/FR2665363A1/fr
Application granted granted Critical
Publication of FR2665363B1 publication Critical patent/FR2665363B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FR9009753A 1990-07-31 1990-07-31 Composition pharmaceutique comprenant une ou des bleomycines, et une ou des proteines inactivant les bleomycines. Expired - Fee Related FR2665363B1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR9009753A FR2665363B1 (fr) 1990-07-31 1990-07-31 Composition pharmaceutique comprenant une ou des bleomycines, et une ou des proteines inactivant les bleomycines.
PCT/FR1991/000623 WO1992002230A1 (fr) 1990-07-31 1991-07-26 Composition pharmaceutique comprenant une ou des bleomycines, et une ou des proteines inactivant les bleomycines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9009753A FR2665363B1 (fr) 1990-07-31 1990-07-31 Composition pharmaceutique comprenant une ou des bleomycines, et une ou des proteines inactivant les bleomycines.

Publications (2)

Publication Number Publication Date
FR2665363A1 FR2665363A1 (fr) 1992-02-07
FR2665363B1 true FR2665363B1 (fr) 1992-12-04

Family

ID=9399268

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9009753A Expired - Fee Related FR2665363B1 (fr) 1990-07-31 1990-07-31 Composition pharmaceutique comprenant une ou des bleomycines, et une ou des proteines inactivant les bleomycines.

Country Status (2)

Country Link
FR (1) FR2665363B1 (fr)
WO (1) WO1992002230A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0667164T3 (da) * 1994-02-10 2000-05-29 Mucos Emulsions Gmbh Anvendelse af hydrolytiske enzymer til formindskelse eller undgåelse af bivirkningerne af bleomycin
US20210244805A1 (en) * 2020-02-11 2021-08-12 University Of South Carolina Pharmaceutical for prevention of bleomycin-induced pulmonary fibrosis

Also Published As

Publication number Publication date
FR2665363A1 (fr) 1992-02-07
WO1992002230A1 (fr) 1992-02-20

Similar Documents

Publication Publication Date Title
MANNICK et al. Prolongation of allograft survival by an alpha globulin isolated from normal blood
NO940663L (no) Lyofilisert polyalkylenoksid modifisert protein og polypeptid komplekser med cyclodextrin
EA200101250A1 (ru) Предупреждение и терапия амилоидогенного заболевания
CA2080462A1 (fr) Utilisation therapeutique de composes liant l'actine
BG102714A (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
DE69010206D1 (de) Stabilisierte protein- oder peptidkonjugate.
ATE430200T1 (de) Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus
BG101118A (en) Therapeutical compounds
DE69226197D1 (de) Hämoglobine als arzneimittelabgabesystem
HK28097A (en) Cyclosporin-containing pharmaceutical composition
KR910002897A (ko) 에리트로포이에틴(epo)펩타이드 및 이에 대한 항체
ATE108662T1 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
PT73161A (fr) Procede pour la preparation de derives de n-(vynblastinoyl-23) aux amino-acids et peptides et son application terapeutique
JP2001506609A (ja) 生理活性の増加した多量体エリスロポエチン
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
WO1996024370B1 (fr) Solutions pharmaceutiques salines non organiques a administration endonasale d'une calcitonine
DE59004445D1 (de) Arzneimittel (calcitoningen verwandte peptide) zur behandlung erektiler dysfunktionen.
DE3584775D1 (de) Zusammensetzung zur behandlung von an haemophilia-a-inhibitor leidenden kranken.
NZ235497A (en) Peptides (possibly related to hirudin) and pharmaceutical compositions for reducing blood coagulation
FR2665363B1 (fr) Composition pharmaceutique comprenant une ou des bleomycines, et une ou des proteines inactivant les bleomycines.
ATE69556T1 (de) Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute.
Jamieson et al. Studies on acute phase proteins of rat serum. III. Site of synthesis of albumin and α1-acid glycoprotein and the contents of these proteins in liver microsome fractions from rats suffering from induced inflammation
PT704528E (pt) Capsides e proteinas recombinantes do virus da doenca hemorragica dos coelhos ("rhdv"), estojos ("kits") de diagnostico e vacinas que as incluem
KR910700259A (ko) T-세포 인지성 펩티드 변형에 의해 면역반응에 영향을 주는 방법

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20090331